News & Events

In this section

Latest News

January 25, 2024

Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline

Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.

November 27, 2023

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.

September 28, 2023

Instem Announces New Software Solution to Support Updated Nitrosamines Guidance

New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)

May 15, 2023

Instem Announces Transfer of ToxHub Platform and launch of Centrus®

New powerful technology and data sharing suite provides a range of translational science solutions

November 02, 2022

Instem Unveils New Additions to its Leading Computational Toxicology Software Suite

New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety

May 10, 2022

Instem Awarded EMA Research Grant

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

November 22, 2021

Instem Expands In Silico Toxicology Service To Meet Growing Demand

Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods

September 01, 2021

Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently

Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support

July 29, 2021

Instem to Release Next Edition of its Leading Computational Toxicology Software Suite

Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance

March 22, 2021

Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development

Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission

March 01, 2021

Instem Announces Acquisition of The Edge; Extends Reach within Discovery R&D

Instem’s Acquisition of Discovery Technology Solutions Provider, The Edge, Represents Another Advancement of its Mission in the Life Sciences

January 27, 2021

Instem Reports Another Year of High Growth for In Silico Solutions

High Demand for Target Safety Assessment Services and Computational Toxicology Solutions Continues Throughout Discovery and Nonclinical

December 10, 2020

Instem Launches In Silico Toxicology Service

Technology-enabled service delivers fast, efficient, comprehensive in silico toxicology predictions

October 21, 2020

Instem Launches New SEND Blog

Bi-weekly blog to provide best-practice insight, observations and opinions to help navigate the challenges and opportunities of SEND

September 10, 2020

Instem Launches New In Silico Toxicology Blog

Value-added blog to provide unique industry and regulatory insight and best practice guidance for computational toxicology scientists and professionals

June 03, 2020

Biotoxtech, South Korea to Deploy Comprehensive Suite of Preclinical Study Management and SEND Software Solutions from Instem

Instem Technology Selected to Streamline Preclinical Operations, Improve Productivity and Ensure SEND Compliance at South Korea’s Largest Preclinical R&D Facility

April 29, 2020

Instem Reporting Strong Start to 2020 for Target Safety Assessment Services

Instem Continues to Ramp up as Demand for Target Safety Assessment Service Reaches New Heights

April 20, 2020

Instem Provides Free SEND Services to COVID-19 Related Research & Development

March 03, 2020

INTOX, India Deploys Provantis Preclinical Software Solution

Provantis Selected to Improve Study Turnaround Times and Further Increase Data Quality at Pune Facility